Clinical Trial Update: "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing Phospholipovit to placebo in patients with combined hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Hyperlipidemia

Drugs mentioned

• Phospholipovit

Snippet

Sponsor: Institute of Biomedical Chemistry, Russia | Conditions: Combined Hyperlipidemia | Phase 2, Phase 3 | Status: COMPLETED